Significant Ownership of New Enterprise Associates 17, L.P.

Signature - Title
/s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer
Location
Timonium, MD
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by New Enterprise Associates 17, L.P..

Notify me when New Enterprise Associates 17, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of New Enterprise Associates 17, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SpyGlass Pharma, Inc. Common Stock, $0.00001 par value per share 22% 7,393,823 Ali Behbahani 09 Feb 2026
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share 9.9% $17,130,522 1,456,677 Ali Behbahani 10 Mar 2026
MBX MBX Biosciences, Inc. Common Stock, par value $0.0001 per share 8.1% $63,340,795 3,619,474 Edward T. Mathers 06 Nov 2025
IVA Inventiva S.A. Ordinary Shares, (euro)0.01 par value per share 6% $31,315,238 8,350,730 New Enterprise Associates 17, L.P. 07 May 2025
NEUE NeueHealth, Inc. Common Stock, $0.0001 par value 0% $0 -$50,344,650 0 -100% New Enterprise Associates 15, L.P. 02 Oct 2025

Schedules 13D/G Reported by New Enterprise Associates 17, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.